spironolactone has been researched along with Peritonitis in 15 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients without hyperkalemia were administrated 100 mg of spironolactone/day." | 9.22 | High Dose Oral Furosemide with Salt Ingestion in the Treatment of Refractory Ascites of Liver Cirrhosis. ( Demir, M; Dogan, O; Ozer, B; Parlakgumus, A; Serin, E; Yakar, T, 2016) |
| " Patients without hyperkalemia were administrated 100 mg of spironolactone/day." | 5.22 | High Dose Oral Furosemide with Salt Ingestion in the Treatment of Refractory Ascites of Liver Cirrhosis. ( Demir, M; Dogan, O; Ozer, B; Parlakgumus, A; Serin, E; Yakar, T, 2016) |
| "Portal hypertension is one of the main consequences of cirrhosis." | 2.43 | Current management of the complications of portal hypertension: variceal bleeding and ascites. ( Calès, P; Dib, N; Oberti, F, 2006) |
| "Peritoneal fibrosis is a complication of patients with long-term continuous ambulatory peritoneal dialysis (CAPD)." | 1.40 | The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis. ( Ding, JL; Hao, JB; Hao, LR; Ren, LS; Zhang, L, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saffouri, GB | 1 |
| Wittich, CM | 1 |
| Zhang, L | 1 |
| Hao, JB | 1 |
| Ren, LS | 1 |
| Ding, JL | 1 |
| Hao, LR | 1 |
| Moret, M | 1 |
| Darbellay, P | 1 |
| Lebowitz, D | 1 |
| Alves, C | 1 |
| Sabeh, N | 1 |
| Carballo, S | 1 |
| Yakar, T | 1 |
| Demir, M | 1 |
| Dogan, O | 1 |
| Parlakgumus, A | 1 |
| Ozer, B | 1 |
| Serin, E | 1 |
| Hou, W | 1 |
| Sanyal, AJ | 1 |
| Dib, N | 1 |
| Oberti, F | 1 |
| Calès, P | 1 |
| Nishimura, H | 1 |
| Ito, Y | 1 |
| Mizuno, M | 1 |
| Tanaka, A | 1 |
| Morita, Y | 1 |
| Maruyama, S | 1 |
| Yuzawa, Y | 1 |
| Matsuo, S | 1 |
| de Luis, DA | 1 |
| Aller, R | 1 |
| Boixeda, D | 1 |
| Ruiz Del Arbol, L | 1 |
| De Argila, CM | 1 |
| Runyon, BA | 1 |
| Antillon, MR | 1 |
| McHutchison, JG | 1 |
| Panos, M | 1 |
| Williams, R | 1 |
| Bruckstein, AH | 1 |
| Kandel, G | 1 |
| Diamant, NE | 1 |
| Selye, H | 3 |
4 reviews available for spironolactone and Peritonitis
| Article | Year |
|---|---|
Ascites: diagnosis and management.
Topics: Ascites; Ascitic Fluid; Cardiac Output; Diet, Sodium-Restricted; Disease Progression; Diuretics; Dru | 2009 |
Current management of the complications of portal hypertension: variceal bleeding and ascites.
Topics: Algorithms; Anti-Bacterial Agents; Ascites; Collateral Circulation; Diuretics; Endoscopy, Gastrointe | 2006 |
Management of the patient with ascites.
Topics: Ascites; Bacterial Infections; Bed Rest; Diagnosis, Differential; Diuretics; Furosemide; Humans; Liv | 1987 |
A clinical view of recent advances in ascites.
Topics: Animals; Ascites; Ascitic Fluid; Bacterial Infections; Blood Volume; Body Water; Extracellular Space | 1986 |
1 trial available for spironolactone and Peritonitis
| Article | Year |
|---|---|
High Dose Oral Furosemide with Salt Ingestion in the Treatment of Refractory Ascites of Liver Cirrhosis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Albumins; Ascites; Bilirubin; Creatinine; End | 2016 |
10 other studies available for spironolactone and Peritonitis
| Article | Year |
|---|---|
83-year-old man with abdominal swelling and lower extremity edema.
Topics: Abdominal Cavity; Aged, 80 and over; Anti-Infective Agents; Ascites; Cefotaxime; Diagnosis, Differen | 2013 |
The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Cilazapril | 2014 |
[Internal medicine in the hospital setting].
Topics: Adrenergic beta-Antagonists; Aminobutyrates; Angiotensin Receptor Antagonists; Asymptomatic Diseases | 2015 |
Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model.
Topics: Animals; Blood Pressure; Blotting, Western; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Fi | 2008 |
Spontaneous bacterial peritonitis caused by Citrobacter diversus: case report.
Topics: Aged; Alcohol Drinking; Ascites; Cefotaxime; Cephalosporins; Citrobacter; Diagnosis, Differential; D | 1997 |
Diuresis increases ascitic fluid opsonic activity in patients who survive spontaneous bacterial peritonitis.
Topics: Amiloride; Ascites; Bacterial Infections; Complement C3; Complement C4; Diuresis; Humans; Liver Cirr | 1992 |
Ascites in cirrhosis: pathophysiology and management.
Topics: Ascites; Diagnosis, Differential; Humans; Inhalation; Liver Cirrhosis; Peritonitis; Spironolactone; | 1988 |
Prevention of indomethacin-induced intestinal ulcers by various catatoxic steroids.
Topics: Adrenal Cortex Hormones; Animals; Antitoxins; Chemical Phenomena; Chemistry; Corticosterone; Ethyles | 1970 |
Effect of catatoxic steroids upon established morbid changes.
Topics: Animals; Digitoxin; Female; Indomethacin; Intestine, Small; Nitriles; Peritonitis; Poisoning; Pregne | 1971 |
Prevention of indomethacin-induced intestinal ulcers by spironolactone and norbolethone.
Topics: Anabolic Agents; Animals; Digestive System; Female; Indomethacin; Peptic Ulcer; Peritonitis; Rats; S | 1969 |